Your browser doesn't support javascript.
loading
Developmental transcription factor NFIB is a putative target of oncofetal miRNAs and is associated with tumour aggressiveness in lung adenocarcinoma.
Becker-Santos, Daiana D; Thu, Kelsie L; English, John C; Pikor, Larissa A; Martinez, Victor D; Zhang, May; Vucic, Emily A; Luk, Margaret Ty; Carraro, Anita; Korbelik, Jagoda; Piga, Daniela; Lhomme, Nicolas M; Tsay, Mike J; Yee, John; MacAulay, Calum E; Lam, Stephen; Lockwood, William W; Robinson, Wendy P; Jurisica, Igor; Lam, Wan L.
Afiliação
  • Becker-Santos DD; Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada. dbecker@bccrc.ca.
  • Thu KL; Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
  • English JC; Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada.
  • Pikor LA; Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
  • Martinez VD; Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
  • Zhang M; Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
  • Vucic EA; Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
  • Luk MT; Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada.
  • Carraro A; Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
  • Korbelik J; Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
  • Piga D; Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
  • Lhomme NM; Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
  • Tsay MJ; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Yee J; Department of Surgery, Vancouver General Hospital, Vancouver, British Columbia, Canada.
  • MacAulay CE; Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
  • Lam S; Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
  • Lockwood WW; Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
  • Robinson WP; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.
  • Jurisica I; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Lam WL; Departments of Medical Biophysics and Computer Science, University of Toronto, Toronto, Ontario, Canada.
J Pathol ; 240(2): 161-72, 2016 10.
Article em En | MEDLINE | ID: mdl-27357447
ABSTRACT
Genes involved in fetal lung development are thought to play crucial roles in the malignant transformation of adult lung cells. Consequently, the study of lung tumour biology in the context of lung development has the potential to reveal key developmentally relevant genes that play critical roles in lung cancer initiation/progression. Here, we describe for the first time a comprehensive characterization of miRNA expression in human fetal lung tissue, with subsequent identification of 37 miRNAs in non-small cell lung cancer (NSCLC) that recapitulate their fetal expression patterns. Nuclear factor I/B (NFIB), a transcription factor essential for lung development, was identified as a potential frequent target for these 'oncofetal' miRNAs. Concordantly, analysis of NFIB expression in multiple NSCLC independent cohorts revealed its recurrent underexpression (in ∼40-70% of tumours). Interrogation of NFIB copy number, methylation, and mutation status revealed that DNA level disruption of this gene is rare, and further supports the notion that oncofetal miRNAs are likely the primary mechanism responsible for NFIB underexpression in NSCLC. Reflecting its functional role in regulating lung differentiation, low expression of NFIB was significantly associated with biologically more aggressive subtypes and, ultimately, poorer survival in lung adenocarcinoma patients. Copyright © 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / MicroRNAs / Fatores de Transcrição NFI / Neoplasias Pulmonares / Invasividade Neoplásica Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / MicroRNAs / Fatores de Transcrição NFI / Neoplasias Pulmonares / Invasividade Neoplásica Idioma: En Ano de publicação: 2016 Tipo de documento: Article